BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ling Y, Zhong J, Luo J. Safety and effectiveness of SARS-CoV-2 vaccines: A systematic review and meta-analysis. J Med Virol 2021. [PMID: 34264528 DOI: 10.1002/jmv.27203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Jia H, Tian M, Wu N, Yang X, Qi J, Ren W, Li F, Bian H. SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms. Front Cell Infect Microbiol 2022;12:869832. [DOI: 10.3389/fcimb.2022.869832] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kang G. SARS-CoV2 vaccine boosters for India. Indian J Med Microbiol 2022:S0255-0857(21)04735-6. [PMID: 34991914 DOI: 10.1016/j.ijmmb.2021.12.015] [Reference Citation Analysis]
3 Tian F, Yang R. Safety and efficacy of COVID-19 vaccines in children and adolescents: A systematic review of randomized controlled trials. J Med Virol 2022. [PMID: 35705969 DOI: 10.1002/jmv.27940] [Reference Citation Analysis]
4 Li M, Yang X, Jiang L, Yang D. Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in healthy individuals: protocol for a systematic review and meta-analysis. BMJ Open 2021;11:e056106. [PMID: 34740936 DOI: 10.1136/bmjopen-2021-056106] [Reference Citation Analysis]
5 Chu CW, Jiesisibieke ZL, Yang YP, Wu PC, Lin HL, Tung TH. Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis. Expert Rev Vaccines 2022. [PMID: 35112938 DOI: 10.1080/14760584.2022.2036128] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fu Y, Zhao J, Wei X, Han P, Yang L, Ren T, Zhan S, Li L. Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies. Front Public Health 2022;10:917732. [DOI: 10.3389/fpubh.2022.917732] [Reference Citation Analysis]
7 Zou Y, Huang D, Jiang Q, Guo Y, Chen C. The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis. Front Public Health 2022;10:940956. [DOI: 10.3389/fpubh.2022.940956] [Reference Citation Analysis]
8 Soegiarto G, Fajar J, Wulandari L, Anshory M, Ilmawan M, Asmiragani A, Illiyana H, Adam A, Lamadi S, Sa'adah U, Yuantoko T, Nanda E, Rachmawati F, Rahmadani N, Talilah R, Katipana M, Susanto S, Hindom M, Anjasari U, Hidayah N, Fadilla N, Lekatompessy V, Phoenna U, Tamara F, Kartini D, Mahendra A, Permana A, Pasaribu E, Dhama K, Harapan H. Seroconversion rates among different designs of COVID-19 vaccines: a network meta-analysis of randomized controlled trials. F1000Res 2022;11:299. [DOI: 10.12688/f1000research.110281.1] [Reference Citation Analysis]
9 Vashishtha VM, Kumar P. Looking to the future: is a universal coronavirus vaccine feasible? Expert Rev Vaccines 2021;:1-4. [PMID: 34968153 DOI: 10.1080/14760584.2022.2020107] [Reference Citation Analysis]
10 Nohl A, Ben Abdallah H, Weichert V, Zeiger S, Ohmann T, Dudda M. A Local Survey of COVID-19: Vaccine Potential Acceptance Rate among Personnel in a Level 1 Trauma Center without Severe COVID-19 Cases. Healthcare (Basel) 2021;9:1616. [PMID: 34946342 DOI: 10.3390/healthcare9121616] [Reference Citation Analysis]
11 Cesari F, Sorrentino S, Gori AM, Rogolino A, De Cristofaro R, Giusti B, Sticchi E, De Candia E, Marcucci R. Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience. Viruses 2022;14:1133. [DOI: 10.3390/v14061133] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ling Y, Zhong J, Luo J. Safety and effectiveness of SARS-CoV-2 vaccines: A systematic review and meta-analysis. J Med Virol 2021. [PMID: 34264528 DOI: 10.1002/jmv.27203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ismail II, Salama S. A systematic review of cases of CNS demyelination following COVID-19 vaccination. J Neuroimmunol 2022;362:577765. [PMID: 34839149 DOI: 10.1016/j.jneuroim.2021.577765] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 21.0] [Reference Citation Analysis]
14 Finsterer J. Polyradiculitis and encephalomyelitis in the same patient following a SARS-CoV-2 vaccination. Neurol Res Pract 2022;4:11. [PMID: 35341482 DOI: 10.1186/s42466-022-00177-w] [Reference Citation Analysis]
15 Deng J, Heybati K, Zhou F. Response to "Safety and effectiveness of SARS-CoV-2 vaccines: A systematic review and meta-analysis". J Med Virol 2021. [PMID: 34387877 DOI: 10.1002/jmv.27269] [Reference Citation Analysis]
16 El Gamal M, Siddiqua A, Abdul WK, Almurshidi BH, Howari FM. Investigation of factors affecting COVID-19 vaccine acceptance among communities of universities in the United Arab Emirates. Hum Vaccin Immunother 2022;:1-9. [PMID: 35594545 DOI: 10.1080/21645515.2022.2068930] [Reference Citation Analysis]
17 Mohseni Afshar Z, Barary M, Hosseinzadeh R, Karim B, Ebrahimpour S, Nazary K, Sio TT, Sullman MJM, Carson-Chahhoud K, Moudi E, Babazadeh A. COVID-19 vaccination challenges: a mini-review. Hum Vaccin Immunother 2022;:1-9. [PMID: 35512088 DOI: 10.1080/21645515.2022.2066425] [Reference Citation Analysis]
18 Du Y, Chen L, Shi Y. Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: a systematic review. Hum Vaccin Immunother 2022;:1-19. [PMID: 35499517 DOI: 10.1080/21645515.2022.2062983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
19 Watanabe M, Nishikawaji Y, Kawakami H, Kosai KI. Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy. Viruses 2021;13:2502. [PMID: 34960772 DOI: 10.3390/v13122502] [Reference Citation Analysis]
20 Ostovan VR, Sahraian MA, Karazhian N, Rostamihosseinkhani M, Salimi M, Marbooti H. Clinical characteristics, radiological features and prognostic factors of transverse myelitis following COVID-19 vaccination: A systematic review. Mult Scler Relat Disord 2022;66:104032. [PMID: 35858499 DOI: 10.1016/j.msard.2022.104032] [Reference Citation Analysis]
21 Moscardino U, Musso P, Inguglia C, Ceccon C, Miconi D, Rousseau C. Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.03.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Lin N, Fu H, Pu D, Quan Y, Li Y, Yin X, Wei Y, Wang H, Ma X, Wei X. Criteria for judging the immune markers of COVID-19 disease vaccines. MedComm (2020) 2022;3:1-12. [PMID: 35005708 DOI: 10.1002/mco2.109] [Reference Citation Analysis]
23 Liu Q, Qin C, Liu M, Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infect Dis Poverty 2021;10:132. [PMID: 34776011 DOI: 10.1186/s40249-021-00915-3] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
24 Sutton N, San Francisco Ramos A, Beales E, Smith D, Ikram S, Galiza E, Hsia Y, Heath PT. Comparing Reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis. Expert Rev Vaccines 2022. [PMID: 35796029 DOI: 10.1080/14760584.2022.2098719] [Reference Citation Analysis]
25 Nunhofer V, Weidner L, Hoeggerl AD, Zimmermann G, Badstuber N, Grabmer C, Jungbauer C, Lindlbauer N, Held N, Pascariuc M, Ortner T, Rohde E, Laner-plamberger S. Persistence of Naturally Acquired and Functional SARS-CoV-2 Antibodies in Blood Donors One Year after Infection. Viruses 2022;14:637. [DOI: 10.3390/v14030637] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]